Seroprevalence surveys suggest that more than a third and possibly more than half of the
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …

Vitamin D deficiency has a high worldwide prevalence, but actions to improve this public
health problem are challenged by the heterogeneity of nutritional and clinical vitamin D …

As a consequence of epidemiological studies showing significant associations of vitamin D
deficiency with a variety of adverse extra-skeletal clinical outcomes including cardiovascular …

Coronavirus disease 2019 (COVID-19) has quickly become a global pandemic. Reports
from different parts of the world indicate that a significant proportion of people who have …

Nutraceuticals have emerged as potential compounds to attenuate the COVID‐19
complications. Precisely, these food additives strengthen the overall COVID treatment and …

In the last 2 years, observational studies have shown that a low 25-hydroxyvitamin D (25
(OH) D) level affected the severity of infection with the novel coronavirus (COVID-19). This …

SARS-CoV-2 virus, infecting human cells via its spike protein, causes Coronavirus disease
2019 (COVID-19). COVID-19 is characterized by shortness of breath, fever, and pneumonia …

The SARS-CoV-2 pandemic has raised particular concern for people with Multiple Sclerosis,
as these people are believed to be at increased risk of infection, especially those being …

Introduction Coronavirus disease (COVID-19) is a global pandemic. Vitamin D deficiency
has been associated with susceptibility to infectious disease. In this study, the association …

Vitamin D is a hormone involved in the regulation of important biological processes such as
signal transduction, immune response, metabolic regulation and also in the nervous and …